Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kohei Arimizu"'
Autor:
Kenji Tsuchihashi, Mamoru Ito, Shuji Arita, Hitoshi Kusaba, Wataru Kusano, Takashi Matsumura, Takafumi Kitazono, Shohei Ueno, Ryosuke Taguchi, Tomoyasu Yoshihiro, Yasuhiro Doi, Kohei Arimizu, Hirofumi Ohmura, Tatsuhiro Kajitani, Kenta Nio, Michitaka Nakano, Kotoe Oshima, Shingo Tamura, Tsuyoshi Shirakawa, Hozumi Shimokawa, Keita Uchino, Fumiyasu Hanamura, Yuta Okumura, Masato Komoda, Taichi Isobe, Hiroshi Ariyama, Taito Esaki, Kazuki Hashimoto, Noritaka Komune, Mioko Matsuo, Keiji Matsumoto, Kaori Asai, Tadamasa Yoshitake, Hidetaka Yamamoto, Yoshinao Oda, Koichi Akashi, Eishi Baba
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Rhabdomyosarcoma is the most common soft tissue sarcoma in children, but rare in adults. Para-meningeal rhabdomyosarcoma in head and neck (PM-HNRMS) is less applicable for surgery due to the anatomic reason. PM-HNRMS has a poor pr
Externí odkaz:
https://doaj.org/article/dd56a19bf0864e60aa13faa99e4c71cb
Autor:
Kohei Arimizu, Gen Hirano, Chinatsu Makiyama, Mioko Matsuo, Takakazu Sasaguri, Akitaka Makiyama
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Abstract Background Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the ca
Externí odkaz:
https://doaj.org/article/9ea41379acb24410a0c3358836535cc7
Autor:
Yoshihiro Matsumoto, Hiroshi Ariyama, Makoto Endo, Tomoyasu Yoshihiro, Koichi Akashi, Hirofumi Ohmura, Kohei Arimizu, Eishi Baba, Kyoko Yamaguchi, Mamoru Ito, Fumiyasu Hanamura, Nokitaka Setsu, Kenro Tanoue, Takashi Imajima, Yudai Shinohara, Yasuharu Nakashima, Satoru Yamaga, Taichi Isobe, Toshifumi Fujiwara, Hitoshi Kusaba, Kenji Tsuchihashi
Publikováno v:
Scientific Reports
Doxorubicin is a first-line therapy for patients with unresectable advanced soft tissue sarcoma (STS). However, because of cardiotoxicities, it is not used for patients with cardiac problems. Eribulin has exhibited efficacy for advanced STS in second
Autor:
Takakazu Sasaguri, Mioko Matsuo, Akitaka Makiyama, Chinatsu Makiyama, Kohei Arimizu, Gen Hirano
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-6 (2018)
Background Nuclear protein in testis (NUT) carcinoma (NC) is a rare epithelial malignancy characterized by rearrangement of the NUT gene on chromosome 15. If NC is not suspected, it is often diagnosed as other malignancies. We present the case of NC
Autor:
Hisanobu Oda, Eishi Baba, Hirofumi Ohmura, Hiroshi Ariyama, Kyoko Yamaguchi, Koichi Akashi, Shiho Kawagoe, Fumiyasu Hanamura, Tanoue Kenrou, Yuzo Matsushita, Hozumi Shimokawa, Hitoshi Kusaba, Keita Uchino, Kohei Arimizu, Mamoru Ito, Yudai Shinohara, Tatsuhiro Kajitani, Taichi Isobe, Kenji Tsuchihashi, Shingo Tamura
Publikováno v:
Journal of Clinical Oncology. 38:35-35
35 Background: Anti-programmed death-1 (PD-1) monoclonal antibody, nivolumab, enhances anti-tumor activity by inhibiting the interaction of PD-1 and programmed death-1 ligand 1 and has shown efficacy for platinum-refractory recurrent or advanced head
Autor:
Masato Komoda, Yuzo Matsushita, Kyoko Inadomi, Kohei Arimizu, Keita Uchino, Tsuyoshi Shirakawa, Hiroshi Ariyama, Akitaka Makiyama, Yudai Shinohara, Tatsuhiro Kajitani, Taito Esaki, Hirofumi Ohmura, Hisanobu Oda, Koichi Akashi, Hitoshi Kusaba, Miyuki Kuwayama, Shuji Arita, Chinatsu Makiyama, Eishi Baba, Gen Hirano
Publikováno v:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 21(3)
Patients with advanced gastric cancer (AGC) are often treated with irinotecan monotherapy as salvage-line therapy. However, the survival benefit of this therapy remains to be elucidated. Medical records of AGC patients who were treated with irinoteca
Autor:
Kohei Arimizu, Taito Esaki, Hirofumi Ohmura, Kenji Mitsugi, Hiroshi Ariyama, Risa Tanaka, Koichi Akashi, Keita Uchino, Eishi Baba, Yuzo Matsushita, Yoshihiro Shibata, Gen Hirano, Miyuki Kuwayama, Kyoko Inadomi, Fumiyasu Hanamura, Shuji Arita, Akitaka Makiyama, Hitoshi Kusaba, Kotoe Takayoshi
Publikováno v:
Anticancer research. 37(5)
Background Significant efficacy of oxaliplatin-based chemotherapy has been demonstrated for advanced gastric cancer (AGC). However, the appropriate dose of oxaliplatin, and the efficacy and toxicity of administration of oxaliplatin subsequent to cisp